Codexis, Inc. (CDXS)
Largest Insider Buys in Sector
CDXS Stock Price History Chart
CDXS Stock Performance
About Codexis, Inc.
Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protein engineering services. In addition, it offers CodeEvolver protein engineering technology platform, which helps in developing and delivering biocatalysts that perform chemical transformations and enhance the efficiency and productivity of manufacturing processes. The company's platform is also used to discover novel biotherapeutic drug candidates for targeted human diseases, as well as for molecular biology and in vitro diagnostic enzymes. It sells its products to pharmaceutical manufacturers through its direct sales and business development force in the United States and Europe. The company was incorporated in 2002 and is headquartered in Redwood City, California.
Insider Activity of Codexis, Inc.
Over the last 12 months, insiders at Codexis, Inc. have bought $156,352 and sold $42,168 worth of Codexis, Inc. stock.
On average, over the past 5 years, insiders at Codexis, Inc. have bought $385,484 and sold $3.61M worth of stock each year.
Highest buying activity among insiders over the last 12 months: DILLY STEPHEN GEORGE (See Remarks) — $201,905. Fitzgerald Margaret Nell (See Remarks) — $20,065. Ryali Sriram (Chief Financial Officer) — $19,856.
The last purchase of 9,000 shares for transaction amount of $15,479 was made by Norrett Kevin (Chief Operating Officer) on 2023‑09‑11.
List of Insider Buy and Sell Transactions, Codexis, Inc.
| 2023-11-15 | Sale | Dorgan Byron L | director | 20,000 0.0289% | $2.11 | $42,168 | +45.24% | |
| 2023-09-11 | Norrett Kevin | Chief Operating Officer | 9,000 0.0126% | $1.72 | $15,479 | +62.64% | ||
| 2023-09-08 | DILLY STEPHEN GEORGE | See Remarks | 58,479 0.0841% | $1.73 | $100,952 | +66.28% | ||
| 2023-09-08 | Ryali Sriram | Chief Financial Officer | 11,650 0.0165% | $1.70 | $19,856 | +66.28% | ||
| 2023-09-08 | Fitzgerald Margaret Nell | See Remarks | 11,834 0.0167% | $1.70 | $20,065 | +66.28% | ||
| 2023-04-18 | Sale | NICOLS JOHN J | director | 35,714 0.0539% | $4.14 | $147,874 | -34.74% | |
| 2023-04-17 | Sale | NICOLS JOHN J | director | 35,714 0.0529% | $4.24 | $151,377 | -37.44% | |
| 2023-03-16 | Sale | NICOLS JOHN J | director | 35,714 0.054% | $4.11 | $146,681 | -34.04% | |
| 2023-03-15 | Sale | NICOLS JOHN J | director | 35,714 0.0533% | $4.09 | $146,131 | -34.62% | |
| 2023-03-08 | Sale | DILLY STEPHEN GEORGE | See Remarks | 26,987 0.0411% | $4.56 | $122,931 | -40.09% | |
| 2023-03-08 | Sale | Norrett Kevin | Chief Operating Officer | 8,258 0.0126% | $4.56 | $37,617 | -40.09% | |
| 2023-03-08 | Sale | Fitzgerald Margaret Nell | See remarks | 7,686 0.0117% | $4.56 | $35,011 | -40.09% | |
| 2023-03-07 | Sale | DILLY STEPHEN GEORGE | See Remarks | 28,088 0.0426% | $4.60 | $129,281 | -40.87% | |
| 2023-03-07 | Sale | Norrett Kevin | Chief Operating Officer | 8,596 0.013% | $4.60 | $39,565 | -40.87% | |
| 2023-03-07 | Sale | Fitzgerald Margaret Nell | See remarks | 8,000 0.0121% | $4.60 | $36,822 | -40.87% | |
| 2023-02-24 | Sale | NICOLS JOHN J | director | 35,714 0.0554% | $4.83 | $172,652 | -42.60% | |
| 2023-02-23 | Sale | NICOLS JOHN J | director | 39,785 0.0589% | $5.36 | $213,220 | -50.50% | |
| 2023-01-24 | Sale | NICOLS JOHN J | director | 35,714 0.0548% | $6.42 | $229,295 | -56.61% | |
| 2022-12-12 | Sale | NICOLS JOHN J | director | 35,714 0.055% | $5.68 | $202,820 | -49.73% | |
| 2022-11-16 | Sale | NICOLS JOHN J | director | 35,714 0.0566% | $6.36 | $227,312 | -44.62% |
Insider Historical Profitability
| DILLY STEPHEN GEORGE | See Remarks | 438878 0.6285% | $3.18 | 1 | 2 | |
| Dorgan Byron L | director | 193461 0.277% | $3.18 | 0 | 9 | |
| Ryali Sriram | Chief Financial Officer | 123441 0.1768% | $3.18 | 1 | 0 | |
| Norrett Kevin | Chief Operating Officer | 98102 0.1405% | $3.18 | 1 | 2 | |
| Fitzgerald Margaret Nell | See Remarks | 81420 0.1166% | $3.18 | 1 | 2 | |
| NICOLS JOHN J | director | 783965 1.1227% | $3.18 | 4 | 31 | <0.0001% |
| KELLEY BERNARD J | director | 206136 0.2952% | $3.18 | 0 | 16 | |
| SHAW ALAN | President and CEO | 202000 0.2893% | $3.18 | 1 | 12 | +25.75% |
| SANGSTER GORDON | SVP & Chief Financial Officer | 134453 0.1925% | $3.18 | 0 | 8 | |
| Lalonde James | SVP, R&D | 133402 0.191% | $3.18 | 0 | 14 | |
| O'Toole David D | SVP & Chief Financial Officer | 115384 0.1652% | $3.18 | 4 | 0 | <0.0001% |
| VIVO VENTURES VII, LLC | 10 percent owner | 112940 0.1617% | $3.18 | 0 | 5 | |
| Vivo Ventures Fund VII, L.P. | 10 percent owner | 90330 0.1294% | $3.18 | 0 | 1 | |
| Anton David L. | SVP, BioIndustrials | 70200 0.1005% | $3.18 | 1 | 1 | +25.75% |
| Sheehy Douglas T. | SVP, General Counsel & Sec. | 69200 0.0991% | $3.18 | 1 | 1 | +25.75% |
| Glaub Kathleen Sereda | director | 63534 0.091% | $3.18 | 0 | 3 | |
| Cheng Pam P. | director | 58719 0.0841% | $3.18 | 0 | 2 | |
| Smith David V | director | 56679 0.0812% | $3.18 | 0 | 1 | |
| Lawson Robert J | SVP and CFO | 44000 0.063% | $3.18 | 2 | 0 | <0.0001% |
| Yang Patrick Y | 42512 0.0609% | $3.18 | 12 | 12 | +15.01% | |
| BARUCH THOMAS R | director | 33093 0.0474% | $3.18 | 1 | 15 | +28.81% |
| WOLF DENNIS P | 30925 0.0443% | $3.18 | 0 | 22 | ||
| Pasternack Bruce A | director | 10000 0.0143% | $3.18 | 3 | 0 | +29.98% |
| Sarret Joseph J. | CBO, President Pharmaceuticals | 2000 0.0029% | $3.18 | 1 | 0 | +25.75% |
| Aldridge Michael D. | See Remarks | 0 0% | $3.18 | 0 | 2 | |
| CMEA VENTURES LIFE SCIENCES 2000 LP | 0 0% | $3.18 | 0 | 1 |
Institutional Investor Ownership
| BlackRock | $23.09M | 9.38 | 6.61M | -8.08% | -$2.03M | <0.01 | |
| Nantahala Capital Management Llc | $15.57M | 6.32 | 4.46M | -2.85% | -$457,277.24 | 1.6 | |
| Fidelity Investments | $15.47M | 6.28 | 4.43M | +1.54% | +$234,447.73 | <0.01 | |
| The Vanguard Group | $14.86M | 6.04 | 4.26M | +3.14% | +$452,907.76 | <0.0001 | |
| Baillie Gifford Co | $12.02M | 4.88 | 3.45M | +0.77% | +$91,493.84 | 0.01 | |
| Opaleye Management Inc | $10.89M | 4.42 | 3.12M | +2.44% | +$259,917.75 | 1.72 | |
| Telemark Asset Management LLC | $9.41M | 3.82 | 2.7M | 0% | +$0 | 1.03 | |
| Casdin Capital | $6.98M | 2.84 | 2M | 0% | +$0 | 0.52 | |
| Nuveen | $5.74M | 2.33 | 1.64M | -19.56% | -$1.39M | <0.01 | |
| Geode Capital Management | $5.45M | 2.22 | 1.56M | +3.19% | +$168,541.08 | <0.0001 | |
| State Street | $5.27M | 2.14 | 1.51M | +1.75% | +$90,931.96 | <0.0001 | |
| Assenagon Asset Management S.A. | $5.08M | 2.07 | 1.46M | 0% | +$0 | 0.01 | |
| Federated Hermes | $4.72M | 1.92 | 1.35M | +0.85% | +$39,960.50 | 0.01 | |
| Ameriprise Financial | $4.53M | 1.84 | 1.3M | +5.43% | +$233,481.01 | <0.01 | |
| Jacobs Levy Equity Management | $3.65M | 1.48 | 1.05M | -23.49% | -$1.12M | 0.02 | |
| Paradigm Capital Management Inc Ny | $3.14M | 1.28 | 900,000 | 0% | +$0 | 0.15 | |
| Two Sigma Advisers LP | $3.03M | 1.23 | 867,700 | -7.18% | -$234,179.00 | 0.01 | |
| Acadian Asset Management | $2.72M | 1.11 | 779,335 | -0.36% | -$9,807.10 | 0.01 | |
| Kent Lake Capital LLC | $2.2M | 0.89 | 629,399 | New | +$2.2M | 0.96 | |
| Northern Trust | $2.06M | 0.84 | 591,677 | -3.52% | -$75,380.52 | <0.0001 | |
| Two Sigma | $1.86M | 0.75 | 531,778 | -8.94% | -$182,216.37 | <0.01 | |
| Alger | $1.77M | 0.72 | 508,095 | +17.35% | +$262,120.01 | 0.01 | |
| Prescott Group Capital Management LLC | $1.58M | 0.64 | 453,125 | -14.59% | -$269,969.38 | 0.18 | |
| Vivo Capital | $1.35M | 0.55 | 388,144 | 0% | +$0 | 0.12 | |
| Renaissance Technologies | $1.27M | 0.52 | 363,986 | New | +$1.27M | <0.01 | |
| Citadel Advisors LLC | $1.23M | 0.5 | 351,546 | +175.52% | +$781,596.26 | <0.01 | |
| Millennium Management LLC | $1.16M | 0.47 | 332,866 | -46.22% | -$998,450.32 | <0.01 | |
| Dimensional Fund Advisors | $884,035.00 | 0.36 | 253,305 | +20.15% | +$148,283.21 | <0.0001 | |
| BNY Mellon | $879,577.00 | 0.36 | 252,028 | -4.73% | -$43,663.35 | <0.0001 | |
| Bridgeway Capital Management | $844,580.00 | 0.34 | 242,000 | +22.84% | +$157,050.00 | 0.02 | |
| Private Advisor Group | $807,379.00 | 0.33 | 231,341 | +22.09% | +$146,073.75 | 0.01 | |
| PLATINUM INVESTMENT MANAGEMENT LTD | $801,538.00 | 0.33 | 229,667 | New | +$801,538.00 | 0.01 | |
| Morgan Stanley | $780,762.00 | 0.32 | 223,714 | -38.74% | -$493,828.11 | <0.0001 | |
| Goldman Sachs | $720,057.00 | 0.29 | 206,320 | -19.07% | -$169,715.26 | <0.0001 | |
| Charles Schwab | $713,893.00 | 0.29 | 204,554 | -3.39% | -$25,058.18 | <0.0001 | |
| Eam Investors | $696,164.00 | 0.28 | 199,474 | New | +$696,164.00 | 0.11 | |
| Royal Bank of Canada | $688,000.00 | 0.28 | 197,261 | +24.7% | +$136,287.90 | <0.0001 | |
| D. E. Shaw & Co. | $591,827.00 | 0.24 | 169,578 | -81.39% | -$2.59M | <0.01 | |
| Barclays | $575,000.00 | 0.23 | 164,576 | -23.61% | -$177,664.57 | <0.0001 | |
| Envestnet Asset Management Inc | $564,155.00 | 0.23 | 161,649 | +34.98% | +$146,185.63 | <0.0001 | |
| Standard Life | $560,428.00 | 0.23 | 160,581 | 0% | +$0 | <0.01 | |
| Perkins Capital Management Inc | $557,000.00 | 0.23 | 159,600 | +242.49% | +$394,367.17 | 0.48 | |
| Cubist Systematic Strategies | $552,097.00 | 0.22 | 158,194 | +140.34% | +$322,385.22 | 0.01 | |
| Engineers Gate Manager Lp | $540,838.00 | 0.22 | 154,968 | -26.65% | -$196,483.39 | 0.01 | |
| WHITE PINE CAPITAL, LLC | $442,739.00 | 0.22 | 152,144 | +2.63% | +$11,360.64 | 0.17 | |
| Ohio Strs | $507,000.00 | 0.21 | 145,300 | -42.45% | -$374,056.43 | <0.01 | |
| Stifel | $483,417.00 | 0.2 | 138,515 | New | +$483,417.00 | <0.01 | |
| AQR Capital | $453,934.00 | 0.18 | 130,067 | -31.17% | -$205,568.06 | <0.01 | |
| LINSCO PRIVATE LEDGER CORP | $409,778.00 | 0.17 | 117,415 | +34.09% | +$104,172.92 | <0.0001 | |
| RhumbLine Advisers | $364,960.00 | 0.15 | 104,577 | +2.8% | +$9,925.19 | <0.0001 |